Last 12 months
Inside the activity.
2 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2024 Filed Feb 6, 2024 20:42 UTC |
Ramos Lara Mario Y.Sr VP Global Product Developm
|
Exercise / conversionCommon Stock | 10,761 | $25.52 | $274,620.72 |
DisclosureSEC source: 0001005229-24-000020 · wk-form4_1707252132.xml · nonDerivative · entry 1 Ramos Lara Mario Y. · CIK 0001747575 · Sr VP Global Product Developm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,027.1895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 7,352.1895 shares of restricted stock issued to reporting person, subject to forfeiture in whole or part; 965.1200 shares become fully vested 5/17/2024, and 2,410.8134 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,976.2561 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024 if reporting person remains an employee of issuer. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 19:25 UTC |
Ramos Lara Mario Y.Sr VP Global Product Developm
|
SaleCommon Stock | 9,071 | $38.50 | $349,233.50 |
DisclosureSEC source: 0001005229-24-000018 · wk-form4_1706901928.xml · nonDerivative · entry 1 Ramos Lara Mario Y. · CIK 0001747575 · Sr VP Global Product Developm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,266.1895 F1 · shares: All shares sold at $38.50 F2 · balance_after: Includes 7,352.1895 shares of restricted stock issued to reporting person, subject to forfeiture in whole or part; 965.1200 shares become fully vested 5/17/2024, and 2,410.8134 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,976.2561 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024 if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:34 UTC |
Abraham Chad RDirector
|
GrantDeferred Stock · Derivative | 6.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000304 · wk-form4_1700606050.xml · derivative · entry 2 Abraham Chad R · CIK 0001538591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180.2017 Underlying: Common Stock · 3,173.9725 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F4 · derivative.exercise_date: Deferred shares will be delivered to the reporting person February 1, 2032, under and subject to the terms of the Plan. F4 · derivative.expiration_date: Deferred shares will be delivered to the reporting person February 1, 2032, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:34 UTC |
Abraham Chad RDirector
|
GrantDeferred Stock · Derivative | 8.0834 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000304 · wk-form4_1700606050.xml · derivative · entry 1 Abraham Chad R · CIK 0001538591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,160.7277 Underlying: Common Stock · 4,152.6443 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person February 1, 2031, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person February 1, 2031, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:31 UTC |
Roedel Kathryn VDirector
|
GrantDeferred Stock · Derivative | 6.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000302 · wk-form4_1700605891.xml · derivative · entry 3 Roedel Kathryn V · CIK 0001321557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180.2017 Underlying: Common Stock · 3,173.9725 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:31 UTC |
Roedel Kathryn VDirector
|
GrantDeferred Stock · Derivative | 8.0834 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000302 · wk-form4_1700605891.xml · derivative · entry 2 Roedel Kathryn V · CIK 0001321557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,160.7277 Underlying: Common Stock · 4,152.6443 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:29 UTC |
Dastoor MichaelDirector
|
GrantDeferred Stock · Derivative | 6.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000300 · wk-form4_1700605758.xml · derivative · entry 2 Dastoor Michael · CIK 0001295399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180.2017 Underlying: Common Stock · 3,173.9725 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on January 1, 2026, under and subject to the terms the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on January 1, 2026, under and subject to the terms the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:23 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 6.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000298 · wk-form4_1700605419.xml · derivative · entry 4 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180.2017 Underlying: Common Stock · 3,173.9725 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:23 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 8.0834 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000298 · wk-form4_1700605419.xml · derivative · entry 3 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,160.7277 Underlying: Common Stock · 4,152.6443 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:23 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 5.3896 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000298 · wk-form4_1700605419.xml · derivative · entry 2 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,790.5002 Underlying: Common Stock · 2,785.1106 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:21 UTC |
Chintapalli AppalPresident of EMEA & APAC
|
GrantCommon Stock | 16.5189 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000296 · wk-form4_1700605306.xml · nonDerivative · entry 1 Chintapalli Appal · CIK 0001783588 · President of EMEA & APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,375.5536 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 8,466.5536 shares of restricted stock issued to reporting person subject to forfeiture in while of part. 870.4408 shares become fully vested 5/17/2024; 2,583.8819 shares become fully vested 50% per year for 2 years beginning 5/16/2024 and 5,012.2309 become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:19 UTC |
Ramos Lara Mario Y.Sr VP Global Product Developm
|
GrantCommon Stock | 14.3363 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000294 · wk-form4_1700605140.xml · nonDerivative · entry 1 Ramos Lara Mario Y. · CIK 0001747575 · Sr VP Global Product Developm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,337.1895 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 7,352.1895 shares of restricted stock issued to reporting person, subject to forfeiture in whole or part; 965.1200 shares become fully vested 5/17/2024, and 2,410.8134 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,976.2561 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024 if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:16 UTC |
Paradowski Mark RSr. VP Information Services
|
GrantCommon Stock | 11.7563 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000292 · wk-form4_1700604988.xml · nonDerivative · entry 1 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,858.2325 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 6,027.2325 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 617.9620 shares become fully vested 5/17/2024, 2,035.3255 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,373.9450 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:13 UTC |
Brant Bert A.Sr VP Global Manufacturing Op
|
GrantCommon Stock | 19.0279 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000290 · wk-form4_1700604780.xml · nonDerivative · entry 1 Brant Bert A. · CIK 0001735968 · Sr VP Global Manufacturing Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,814.9603 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 9,758.9603 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,301.0796 shares become fully vested 5/17/2024, 3,256.9256 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 5,200.9551 shares become fully vested 33.33% per year for three years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:07 UTC |
Wilson David J.Director · President & CEO
|
GrantCommon Stock | 109.8194 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000286 · wk-form4_1700604447.xml · nonDerivative · entry 1 Wilson David J. · CIK 0001629079 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,771.4282 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 56,289.4282 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 5,124.9099 shares become fully vested 5/17/2024, and 18,633.7045 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 32,530.8138 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:09 UTC |
Korman Alan SSr VP, Gen'l Counsel & Sec
|
GrantCommon Stock | 20.2785 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000288 · wk-form4_1700604553.xml · nonDerivative · entry 1 Korman Alan S · CIK 0001509464 · Sr VP, Gen'l Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,344.0386 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 10,399.0386 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,299.0435 shares become fully vested 5/17/2024, and 3,460.3570 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 5,639.6381 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 22:05 UTC |
Schadeberg TerryPresident of the Americas
|
GrantCommon Stock | 18.6188 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000284 · wk-form4_1700604312.xml · nonDerivative · entry 1 Schadeberg Terry · CIK 0001875766 · President of the Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,022.6589 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 9,533.6589 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 3,460.3570 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 6,073.3019 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:56 UTC |
Rustowicz Gregory PExecutive VP Finance, CFO
|
GrantCommon Stock | 28.4267 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000282 · wk-form4_1700603764.xml · nonDerivative · entry 1 Rustowicz Gregory P · CIK 0001527862 · Executive VP Finance, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,757.4854 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 14,577.4854 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,865.0845 shares become fully vested 5/17/2024, and 4,759.8888 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 7,952.5121 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:46 UTC |
Aghili AzizDirector
|
GrantDeferred Stock · Derivative | 6.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000280 · wk-form4_1700603178.xml · derivative · entry 3 Aghili Aziz · CIK 0001524680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,180.2017 Underlying: Common Stock · 3,173.9725 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F4 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. F4 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:46 UTC |
Aghili AzizDirector
|
GrantDeferred Stock · Derivative | 8.0834 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000280 · wk-form4_1700603178.xml · derivative · entry 2 Aghili Aziz · CIK 0001524680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,160.7277 Underlying: Common Stock · 4,152.6443 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on December 31, 2025, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on December 31, 2025, under and subject to the terms of the Plan. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:34 UTC |
Williams AdrienneSr. Vice President & CHRO
|
GrantCommon Stock | 13.2941 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000278 · wk-form4_1700602469.xml · nonDerivative · entry 1 Williams Adrienne · CIK 0001876305 · Sr. Vice President & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,368.9063 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 6,813.9063 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 645.4496 shares become fully vested 5/17/2024, 2,192.2006 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,976.2561 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| November 16, 2023 Filed May 24, 2024 19:01 UTC |
Paradowski Mark RSr. VP Information Services
|
PurchaseCommon Stock | 4 | $35.27 | $141.08 |
DisclosureSEC source: 0001005229-24-000156 · wk-form4_1716577256.xml · nonDerivative · entry 2 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,882.2775 F1 · shares: Shares were acquired under a broker automatic dividend reinvestment plan. Read SEC document |
| November 16, 2023 Filed Jun 5, 2024 18:52 UTC Amendment |
Paradowski Mark RSr. VP Information Services
|
PurchaseCommon Stock | 4 | $35.27 | $141.08 |
DisclosureSEC source: 0001005229-24-000198 · wk-form4a_1717613510.xml · nonDerivative · entry 2 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,825.2775 F1 · shares: Shares were acquired under a broker automatic dividend reinvestment plan. F2 · balance_after: Includes 5,416.3202 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,020.4198 shares become fully vested 5/16/2025, and 2,255.9004 shares become fully vested 50% per year for 2 years beginning 5/22/2025, and 2,140 shares become fully vested 33.33% per year for three years beginning 5/20/2025, if reporting person remains an employee of issuer. F3 · balance_after: This amendment is being filed to correct the amount of securities beneficially owned following the reported transactions due to incorrect Form 4 filed on May 22, 2024 which has been amended on Form 4A filed on June 5, 2024. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:47 UTC |
Dastoor MichaelDirector
|
GrantDeferred Stock · Derivative | 5.9725 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000261 · wk-form4_1692820030.xml · derivative · entry 2 Dastoor Michael · CIK 0001295399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173.9725 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on January 1, 2026, under and subject to the terms the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on January 1, 2026, under and subject to the terms the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:45 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 5.9725 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000259 · wk-form4_1692819908.xml · derivative · entry 4 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173.9725 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:45 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 7.7503 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000259 · wk-form4_1692819908.xml · derivative · entry 3 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,152.6443 Underlying: Common Stock · 4,144.894 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:45 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 5.1675 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000259 · wk-form4_1692819908.xml · derivative · entry 2 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,785.1106 Underlying: Common Stock · 2,779.9431 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:40 UTC |
Roedel Kathryn VDirector
|
GrantDeferred Stock · Derivative | 5.9725 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000257 · wk-form4_1692819646.xml · derivative · entry 3 Roedel Kathryn V · CIK 0001321557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173.9725 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:40 UTC |
Roedel Kathryn VDirector
|
GrantDeferred Stock · Derivative | 7.7503 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000257 · wk-form4_1692819646.xml · derivative · entry 2 Roedel Kathryn V · CIK 0001321557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,152.6443 Underlying: Common Stock · 4,144.894 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:33 UTC |
Abraham Chad RDirector
|
GrantDeferred Stock · Derivative | 5.9725 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000253 · wk-form4_1692819209.xml · derivative · entry 2 Abraham Chad R · CIK 0001538591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173.9725 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F4 · derivative.exercise_date: Deferred shares will be delivered to the reporting person February 1, 2032, under and subject to the terms of the Plan. F4 · derivative.expiration_date: Deferred shares will be delivered to the reporting person February 1, 2032, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:33 UTC |
Abraham Chad RDirector
|
GrantDeferred Stock · Derivative | 7.7503 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000253 · wk-form4_1692819209.xml · derivative · entry 1 Abraham Chad R · CIK 0001538591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,152.6443 Underlying: Common Stock · 4,144.894 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person February 1, 2031, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person February 1, 2031, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:38 UTC |
Aghili AzizDirector
|
GrantDeferred Stock · Derivative | 5.9725 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000255 · wk-form4_1692819476.xml · derivative · entry 3 Aghili Aziz · CIK 0001524680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,173.9725 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F4 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. F4 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:38 UTC |
Aghili AzizDirector
|
GrantDeferred Stock · Derivative | 7.7503 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000255 · wk-form4_1692819476.xml · derivative · entry 2 Aghili Aziz · CIK 0001524680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,152.6443 Underlying: Common Stock · 4,144.894 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents additional deferred stock units attributable to dividend reinvestment. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on December 31, 2025, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on December 31, 2025, under and subject to the terms of the Plan. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:30 UTC |
Wilson David J.Director · President & CEO
|
GrantCommon Stock | 105.2942 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000251 · wk-form4_1692819034.xml · nonDerivative · entry 1 Wilson David J. · CIK 0001629079 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,661.6088 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 56,179.6088 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 5,115.0116 shares become fully vested 5/17/2024, and 18,597.5031 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 32,467.0941 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:28 UTC |
Williams AdrienneSr. Vice President & CHRO
|
GrantCommon Stock | 12.7463 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000249 · wk-form4_1692818919.xml · nonDerivative · entry 1 Williams Adrienne · CIK 0001876305 · Sr. Vice President & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,355.6122 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 6,800.6122 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 644.2030 shares become fully vested 5/17/2024, 2,187.9416 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,968.4676 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:26 UTC |
Schadeberg TerryPresident of the Americas
|
GrantCommon Stock | 17.8516 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000247 · wk-form4_1692818811.xml · nonDerivative · entry 1 Schadeberg Terry · CIK 0001875766 · President of the Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,004.0401 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 9,515.0401 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 3,453.6342 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 6,061.4059 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:25 UTC |
Rustowicz Gregory PExecutive VP Finance, CFO
|
GrantCommon Stock | 27.2554 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000245 · wk-form4_1692818694.xml · nonDerivative · entry 1 Rustowicz Gregory P · CIK 0001527862 · Executive VP Finance, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,729.0587 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 14,549.0587 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,861.4823 shares become fully vested 5/17/2024, and 4,750.6413 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 7,936.9351 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:23 UTC |
Ramos Lara Mario Y.Sr VP Global Product Developm
|
GrantCommon Stock | 13.7456 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000243 · wk-form4_1692818587.xml · nonDerivative · entry 1 Ramos Lara Mario Y. · CIK 0001747575 · Sr VP Global Product Developm 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,322.8532 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 7,337.8532 shares of restricted stock issued to reporting person, subject to forfeiture in whole or part; 963.2560 shares become fully vested 5/17/2024, and 2,406.1296 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,968.4676 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024 if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:20 UTC |
Paradowski Mark RSr. VP Information Services
|
GrantCommon Stock | 11.2721 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000240 · wk-form4_1692818422.xml · nonDerivative · entry 1 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,846.4762 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 6,015.4762 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 616.7685 shares become fully vested 5/17/2024, 2,031.3713 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 3,367.3364 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:14 UTC |
Korman Alan SSr VP, Gen'l Counsel & Sec
|
GrantCommon Stock | 19.4427 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000238 · wk-form4_1692818063.xml · nonDerivative · entry 1 Korman Alan S · CIK 0001509464 · Sr VP, Gen'l Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,323.7601 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 10,378.7601 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,296.5345 shares become fully vested 5/17/2024, and 3,453.6342 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 5,628.5914 shares become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:11 UTC |
Chintapalli AppalPresident of EMEA & APAC
|
GrantCommon Stock | 15.8382 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000236 · wk-form4_1692817879.xml · nonDerivative · entry 1 Chintapalli Appal · CIK 0001783588 · President of EMEA & APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,359.0347 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 8,450.0347 shares of restricted stock issued to reporting person subject to forfeiture in while of part. 868.7596 shares become fully vested 5/17/2024; 2,578.8619 shares become fully vested 50% per year for 2 years beginning 5/16/2024 and 5,002.4132 become fully vested 33.33% per year for 3 years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 19:08 UTC |
Brant Bert A.Sr VP Global Manufacturing Op
|
GrantCommon Stock | 18.2439 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000234 · wk-form4_1692817684.xml · nonDerivative · entry 1 Brant Bert A. · CIK 0001735968 · Sr VP Global Manufacturing Op 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,795.9324 F1 · shares: Represents additional restricted stock units attributable to dividend reinvestment. F2 · balance_after: Includes 9,739.9324 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,298.5667 shares become fully vested 5/17/2024, 3,250.5980 shares become fully vested 50% per year for 2 years beginning 5/16/2024, and 5,190.7677 shares become fully vested 33.33% per year for three years beginning 5/22/2024, if reporting person remains an employee of issuer. Read SEC document |
| August 17, 2023 Filed May 24, 2024 19:01 UTC |
Paradowski Mark RSr. VP Information Services
|
PurchaseCommon Stock | 4 | $37.07 | $148.28 |
DisclosureSEC source: 0001005229-24-000156 · wk-form4_1716577256.xml · nonDerivative · entry 1 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,878.2775 F1 · shares: Shares were acquired under a broker automatic dividend reinvestment plan. Read SEC document |
| August 17, 2023 Filed Jun 5, 2024 18:52 UTC Amendment |
Paradowski Mark RSr. VP Information Services
|
PurchaseCommon Stock | 4 | $37.07 | $148.28 |
DisclosureSEC source: 0001005229-24-000198 · wk-form4a_1717613510.xml · nonDerivative · entry 1 Paradowski Mark R · CIK 0001582856 · Sr. VP Information Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,821.2775 F1 · shares: Shares were acquired under a broker automatic dividend reinvestment plan. F2 · balance_after: Includes 5,416.3202 shares of restricted stock issued to reporting person subject to forfeiture in whole or part; 1,020.4198 shares become fully vested 5/16/2025, and 2,255.9004 shares become fully vested 50% per year for 2 years beginning 5/22/2025, and 2,140 shares become fully vested 33.33% per year for three years beginning 5/20/2025, if reporting person remains an employee of issuer. F3 · balance_after: This amendment is being filed to correct the amount of securities beneficially owned following the reported transactions due to incorrect Form 4 filed on May 22, 2024 which has been amended on Form 4A filed on June 5, 2024. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:43 UTC |
Beliveau-Dunn JeanneDirector
|
GrantDeferred Stock · Derivative | 3,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000219 · wk-form4_1690393392.xml · derivative · entry 2 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,092.8371 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents deferred stock units granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · balance_after: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:40 UTC |
Roedel Kathryn VDirector
|
GrantDeferred Stock · Derivative | 3,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000217 · wk-form4_1690393243.xml · derivative · entry 2 Roedel Kathryn V · CIK 0001321557 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,312.894 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents deferred stock units granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. F3 · derivative.exercise_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. F3 · balance_after: Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:37 UTC |
Abraham Chad RDirector
|
GrantDeferred Stock · Derivative | 3,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000215 · wk-form4_1690393021.xml · derivative · entry 1 Abraham Chad R · CIK 0001538591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,312.894 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents deferred stock units granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on February 1, 2032, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on February 1, 2032, under and subject to the terms of the Plan. F4 · balance_after: 4,144.8940 deferred shares will be delivered to the reporting person on February 1, 2031, and 3,168 deferred shares will be delivered to the reporting person on February 1, 2032, under and subject to the terms of the Plan. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:35 UTC |
Aghili AzizDirector
|
GrantDeferred Stock · Derivative | 3,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001005229-23-000213 · wk-form4_1690392903.xml · derivative · entry 2 Aghili Aziz · CIK 0001524680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,312.894 Underlying: Common Stock · 3,168 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock. F2 · shares: Represents deferred stock units granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. F3 · derivative.exercise_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. F3 · derivative.expiration_date: Deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. F4 · balance_after: 4,144.8940 deferred shares will be delivered to the reporting person on December 31, 2025 and 3,168 deferred shares will be delivered to the reporting person on June 1, 2026, under and subject to the terms of the Plan. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:22 UTC |
Yeung RebeccaDirector
|
GrantCommon Stock | 3,168 | $41.04 | $130,014.72 |
DisclosureSEC source: 0001005229-23-000211 · wk-form4_1690392160.xml · nonDerivative · entry 1 Yeung Rebecca · CIK 0001962960 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,168 F1 · shares: Represents shares granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. Read SEC document |
| July 24, 2023 Filed Jul 26, 2023 17:19 UTC |
MITTS HEATH ADirector
|
GrantCommon Stock | 3,168 | $41.04 | $130,014.72 |
DisclosureSEC source: 0001005229-23-000209 · wk-form4_1690391991.xml · nonDerivative · entry 1 MITTS HEATH A · CIK 0001339142 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,119 F1 · shares: Represents shares granted to reporting person under the Columbus McKinnon Corporation 2016 Long Term Incentive Plan as amended and restated June 5, 2019, and further amended effective April 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.